These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 37633753)

  • 1. Inflammasome assembly in neurodegenerative diseases.
    Singh J; Habean ML; Panicker N
    Trends Neurosci; 2023 Oct; 46(10):814-831. PubMed ID: 37633753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Inflammasome in Neurodegenerative Diseases.
    Piancone F; La Rosa F; Marventano I; Saresella M; Clerici M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS.
    Clénet ML; Keaney J; Gillet G; Valadas JS; Langlois J; Cardenas A; Gasser J; Kadiu I
    Front Immunol; 2023; 14():1190219. PubMed ID: 37575265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter injury across neurodegenerative disease.
    Festa LK; Grinspan JB; Jordan-Sciutto KL
    Trends Neurosci; 2024 Jan; 47(1):47-57. PubMed ID: 38052682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of NLRP3 activation and pathology during neurodegeneration.
    Jose S; Groves NJ; Roper KE; Gordon R
    Int J Biochem Cell Biol; 2022 Oct; 151():106273. PubMed ID: 35926782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases.
    Guan Y; Han F
    Front Integr Neurosci; 2020; 14():37. PubMed ID: 32792920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytes: The Stars in Neurodegeneration?
    Stoklund Dittlau K; Freude K
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
    Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
    Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasome activation in neurodegenerative diseases.
    Ravichandran KA; Heneka MT
    Essays Biochem; 2021 Dec; 65(7):885-904. PubMed ID: 34846519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative Disease and the NLRP3 Inflammasome.
    Holbrook JA; Jarosz-Griffiths HH; Caseley E; Lara-Reyna S; Poulter JA; Williams-Gray CH; Peckham D; McDermott MF
    Front Pharmacol; 2021; 12():643254. PubMed ID: 33776778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Cell Type-specific Localization of Inflammasome Sensors in the Spinal Cord of SOD1
    Hummel C; Leylamian O; Pösch A; Weis J; Aronica E; Beyer C; Johann S
    Neuroscience; 2021 May; 463():288-302. PubMed ID: 33781799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications.
    Yang K; Wang X; Pan H; Wang X; Hu Y; Yao Y; Zhao X; Sun T
    Front Immunol; 2024; 15():1441385. PubMed ID: 39076969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
    Fang M; Liu Y; Huang C; Fan S
    Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases.
    Brahadeeswaran S; Sivagurunathan N; Calivarathan L
    Mol Neurobiol; 2022 Apr; 59(4):2288-2304. PubMed ID: 35066762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Role of Long Noncoding RNAs in Regulating Inflammasome-Mediated Neurodegeneration in Parkinson's Disease.
    Sivagurunathan N; Rahamathulla MP; Al-Dossary H; Calivarathan L
    Mol Neurobiol; 2024 Jul; 61(7):4619-4632. PubMed ID: 38105409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.